BRIEF published on 06/30/2026 at 19:13, 1 month 7 days ago ABIONYX Pharma obtient des fonds pour faire progresser le traitement de la septicémie ABIONYX Pharma CER-001 Traitement De La Septicémie Plateforme ApoA-I Financement Financier
BRIEF published on 06/30/2026 at 19:13, 1 month 7 days ago ABIONYX Pharma en pleine expansion après son Assemblée Générale ABIONYX Pharma Sepsis CER-001 Assemblée Générale 2026 Plateforme ApoA-I
BRIEF published on 06/30/2026 at 19:13, 1 month 7 days ago ABIONYX Pharma Secures Funding to Advance Sepsis Treatment ABIONYX Pharma CER-001 Financial Funding Sepsis Treatment ApoA-I Platform
PRESS RELEASE published on 06/30/2026 at 19:08, 1 month 7 days ago Informations privilégiées / Autres communiqués ABIONYX Pharma change d'échelle suite à la sécurisation des moyens de son ambition et ouvre un nouveau cycle de création de valeur dans les inflammations sévères et le sepsis ABIONYX Pharma Sepsis Création De Valeur Innovantes Inflammations Sévères
PRESS RELEASE published on 06/30/2026 at 19:08, 1 month 7 days ago Inside Information / Other news releases ABIONYX Pharma scales up operations after securing resources, focusing on value creation in inflammation and sepsis treatment. Updates on pivotal clinical trial, financial visibility, and scientific platform development Financial Resources Clinical Trial ABIONYX Pharma Sepsis Inflammation Treatment
BRIEF published on 06/18/2026 at 07:35, 1 month 20 days ago ABIONYX Pharma finalise avec succès un financement de 33 millions d'euros. Augmentation De Capital ABIONYX Pharma Fenja Capital Financement Par Obligations Recherche Sur La Septicémie
BRIEF published on 06/18/2026 at 07:35, 1 month 20 days ago ABIONYX Pharma Completes Successful EUR 33 Million Financing Capital Increase Bond Financing ABIONYX Pharma Fenja Capital Sepsis Research
BRIEF published on 06/18/2026 at 07:35, 1 month 20 days ago ABIONYX Pharma réussit son augmentation de capital Augmentation De Capital Essai Clinique Financement Obligataire Sepsis Fenja Capital
BRIEF published on 06/18/2026 at 07:35, 1 month 20 days ago ABIONYX Pharma successfully completes its capital increase Capital Increase Clinical Trial Bond Financing Sepsis Fenja Capital
PRESS RELEASE published on 06/18/2026 at 07:30, 1 month 20 days ago Inside Information / Other news releases ABIONYX Pharma successfully completes financing, raising EUR 33 M. Capital increase and bonds financing secured, enhancing financial position for future growth and clinical trials Financing Clinical Trials Capital Increase ABIONYX Pharma Bonds Financing
Published on 08/07/2026 at 23:15, 19 hours 5 minutes ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 19 hours 20 minutes ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 19 hours 50 minutes ago UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 20 hours 5 minutes ago Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services
Published on 08/08/2026 at 16:25, 1 hour 55 minutes ago Bybit Sues North Korea and Lazarus Group, Secures Preliminary Injunction Freezing Stolen Assets in Landmark Crypto Asset Recovery Effort
Published on 08/07/2026 at 23:21, 18 hours 59 minutes ago EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 22 hours 50 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 23 hours 5 minutes ago ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 1 day ago Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:54, 23 hours 26 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 23 hours 26 minutes ago Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 23 hours 40 minutes ago Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 23 hours 40 minutes ago Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 1 day ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026
